Corticosteroids Before Cataract Surgery: Safety and Recommendations
Corticosteroids are generally safe to use before cataract surgery, but chronic systemic or high-dose inhaled corticosteroid use increases the risk of cataract formation itself—not surgical complications—and should be minimized when possible prior to surgery.
Understanding the Context
The question of steroid safety "prior to" cataract surgery requires distinguishing between two clinical scenarios:
Chronic Steroid Use Leading to Surgery
- Long-term systemic or inhaled corticosteroids are established risk factors for cataract development, particularly posterior subcapsular (PSC) cataracts 1, 2, 3.
- Prolonged use of high-dose inhaled corticosteroids (>1 mg beclomethasone/budesonide daily for >2 years) significantly increases cataract extraction risk (OR 3.40) 1.
- Combined inhaled and oral corticosteroid use carries the highest risk for PSC cataract development (OR 4.76) over 10 years 3.
- Individual susceptibility varies considerably, and no truly "safe" dose exists for preventing steroid-induced cataracts 2.
Perioperative Steroid Administration
There is no contraindication to using corticosteroids immediately before or during cataract surgery—in fact, they are standard postoperative care:
- Intravitreal triamcinolone administered at the time of cataract surgery is safe and effective for preventing postoperative inflammation, with no cases of severe inflammation, cystoid macular edema, or infection reported 4.
- Intracanalicular dexamethasone inserts placed during surgery significantly reduce postoperative inflammation (RR 1.63 for anterior chamber cell clearance by day 14) and pain (RR 1.59 by day 8) with lower adverse event rates compared to placebo 5.
- Sustained-release corticosteroid formulations demonstrate comparable safety profiles to traditional topical steroids 6, 7.
Clinical Algorithm for Steroid Management
For Patients on Chronic Steroids Awaiting Surgery:
- Document the indication for steroid therapy and assess whether dose reduction or alternative therapy is feasible before surgery 8.
- Recognize that cataract formation has already occurred if surgery is planned—the goal is preventing further progression, not reversing existing damage 2, 3.
- Do not abruptly discontinue systemic steroids if medically necessary, as this poses greater systemic risks than proceeding with surgery.
For Perioperative Steroid Use:
- Corticosteroids are the standard of care postoperatively and can be safely administered intraoperatively via intravitreal injection or sustained-release devices 4, 5.
- Combination therapy with NSAIDs and corticosteroids is superior to corticosteroids alone for reducing postoperative inflammation and preventing cystoid macular edema (OR 0.21 for CME at 4-8 weeks) 9.
- Standard versus "soft" topical steroids show comparable efficacy for controlling postoperative inflammation, with only minor differences in anterior chamber flare at day 7 6.
Key Caveats and Pitfalls
Common Misconception: The concern about steroids "prior to" cataract surgery often confuses chronic steroid-induced cataract formation with perioperative steroid safety—these are distinct issues 8.
Monitoring Requirements: Patients on chronic steroids require careful preoperative assessment for steroid-induced complications (glaucoma, delayed wound healing) but can safely proceed with surgery 8.
Cost Considerations: Sustained-release corticosteroid devices (dexamethasone insert, intravitreal suspension) are significantly more expensive ($531-538 per dose) than traditional topical drops, with utilization rates remaining low (0.8-1.7%) despite convenience advantages 7.